Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:124-128
Published online before print December 9, 2004, doi: 10.1161/01.STR.0000150503.10480.a7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/1/124    most recent
01.STR.0000150503.10480.a7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfaffenberger, S.
Right arrow Articles by Gottsauner-Wolf, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfaffenberger, S.
Right arrow Articles by Gottsauner-Wolf, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Thrombolysis
Right arrow Other Stroke Treatment - Medical
Right arrow Arterial thrombosis
Right arrow Acute Cerebral Infarction
Right arrow Acute Stroke Syndromes
Right arrow Fibrinolysis

(Stroke. 2005;36:124.)
© 2005 American Heart Association, Inc.


Original Contributions

Can a Commercial Diagnostic Ultrasound Device Accelerate Thrombolysis?

An In Vitro Skull Model

Stefan Pfaffenberger, MD; Branka Devcic-Kuhar, PhD; Christian Kollmann, PhD; Stefan P. Kastl; Christoph Kaun; Walter S. Speidl, MD; Thomas W. Weiss, MD; Svitlana Demyanets, MD; Robert Ullrich, MD; Heinz Sochor, MD; Christian Wöber, MD; Josef Zeitlhofer, MD, PhD; Kurt Huber, MD; Martin Gröschl, PhD; Ewald Benes, PhD; Gerald Maurer, MD; Johann Wojta, PhD Michael Gottsauner-Wolf, MD

From the Departments of Internal Medicine II (S.P., S.P.K., C. Kaun, W.S.S., T.W.W., S.D., H.S., K.H., G.M., J.W., M.G.-W.), Biomedical Engineering and Physics (C. Kollman), Pathology (R.U.), and Neurology (C.W., J.Z.), University of Vienna, Austria; and Institute of General Physics (B.D.-K., M.G., E.B.), Vienna University of Technology, Austria.

Correspondence to Dr Michael Gottsauner-Wolf, Department of Internal Medicine II, University of Vienna, A-1090 Vienna, Waehringer Guertel 18-20, Austria. E-mail michael.gottsauner-wolf{at}univie.ac.at

Background and Purpose— Recently, 3 clinical trials revealed encouraging results in recanalization and clinical outcome in acute stroke patients when 2-MHz transcranial Doppler monitoring was applied. This study investigated whether a 1.8-MHz commercial diagnostic ultrasound device has the potential to facilitate thrombolysis using an in vitro stroke model.

Methods— Duplex-Doppler, continuous wave-Doppler, and pulsed wave (PW)-Doppler were compared on their impact on recombinant tissue plasminogen activator (rtPA)–mediated thrombolysis. Blood clots were transtemporally sonicated in a human stroke model. Furthermore, ultrasound attenuation of 5 temporal bones of different thickness was determined.

Results— In comparison, only PW-Doppler accelerated rtPA–mediated thrombolysis significantly. Without temporal bone, PW-Doppler plus rtPA showed a significant enhancement in relative clot weight loss of 23.7% when compared with clots treated with rtPA only (33.9±5.5% versus 27.4±5.2%; P<0.0005). Ultrasound attenuation measurements revealed decreases of the output intensity of 86.8% (8.8 dB) up to 99.2% (21.2 dB), depending on temporal bone thickness (1.91 to 5.01 mm).

Conclusion— Without temporal bone, PW-Doppler significantly enhanced thrombolysis. However, because of a high attenuation of ultrasound by temporal bone, no thrombolytic effect was observed in our in vitro model, although Doppler imaging through the same temporal bone was still possible.


Key Words: middle cerebral artery • stroke • thrombolysis • ultrasonography, Doppler, trnascranial




This article has been cited by other articles:


Home page
StrokeHome page
J. Eggers, I. R. Konig, B. Koch, G. Handler, and G. Seidel
Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study
Stroke, May 1, 2008; 39(5): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Reinhard, T. Els, and A. Hetzel
Response to Letter by Gerriets et al
Stroke, February 1, 2007; 38(2): 252 - 252.
[Full Text] [PDF]


Home page
StrokeHome page
F. Schneider, T. Gerriets, M. Walberer, C. Mueller, R. Rolke, B. M. Eicke, J. Bohl, O. Kempski, M. Kaps, G. Bachmann, et al.
Brain Edema and Intracerebral Necrosis Caused by Transcranial Low-Frequency 20-kHz Ultrasound: A Safety Study in Rats
Stroke, May 1, 2006; 37(5): 1301 - 1306.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Pfaffenberger, J. Wojta, and M. Gottsauner-Wolf
High-Frequency Transtemporal Sonothrombolysis
Stroke, July 1, 2005; 36(7): 1356 - 1357.
[Full Text] [PDF]


Home page
StrokeHome page
M. Daffertshofer, A. Gass, P. Ringleb, M. Sitzer, U. Sliwka, T. Els, O. Sedlaczek, W. J. Koroshetz, and M. G. Hennerici
Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia: Increased Risk of Hemorrhage With Combined Ultrasound and Tissue Plasminogen Activator: Results of a Phase II Clinical Trial
Stroke, July 1, 2005; 36(7): 1441 - 1446.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Meairs, C.-E. Dempfle, S. Pfaffenberger, W. S. Speidl, J. Wojta, and M. Gottsauner-Wolf
In Vitro Models for Assessing Transcranial Ultrasound-Enhanced Thrombolysis * Response:
Stroke, May 1, 2005; 36(5): 929 - 931.
[Full Text] [PDF]